Drug Safety and Availability > FDA Drug Safety Communication: Updated FDA review concludes that use of type 2 diabetes medicine pioglitazone may be linked to an increased risk of bladder cancer 12 diciembre, 2016 administrador El rincón del inquieto http://www.fda.gov/Drugs/DrugSafety/ucm519616.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery